Neurotherapeutics · 2024 · 24 citations · 27 references
MedicineNeurologyNeuroscienceClinical NeuroscienceCognitive NeurologyDementiaAlzheimer DiseaseCognitive ImpairmentDementia TreatmentNeurodegenerative Disease PharmacotherapyNeurostimulationLong-term Disability BenefitsLong-term Efficacy AssessmentLong-term Efficacy EvaluationNeuromodulation TherapyPrefrontal Cortex FunctionSham TreatmentTranscranial Magnetic StimulationTreatment Of Cognitive Symptoms
We report results of a large multisite double-blind randomized trial investigating the short and long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) applied to patients with Alzheimer's disease (AD) at mild to moderate stages, in doses of either 2 or 4 weeks of treatment (5 days/week), whilst compared with 4 weeks of sham rTMS. Randomization to treatment group was stratified based on age and severity. The objectives of this study were to: 1) investigate the efficacy of active rTMS versus sham, 2) investigate the effect of dose of treatment (2 or 4 weeks), and 3) investigate the length of benefits from treatment. The rTMS pulses (20 Hz, 30 pulses/train, 25 trains, 10-s intertrain interval) were applied serially to the left and right dorsolateral prefrontal cortex using neuro-navigation. We compared the primary outcome measure's (ADAS-Cog) score changes from pre- to post-treatment, with assessments at baseline and 4 more times up to 6 months post-treatment. Data of 135 patients were analyzed. The mean total ADAS-Cog score at baseline did not differ between the active and sham treatment groups, nor across the three study sites. The overall results show significant cognitive improvement after treatment up to two months post-treatment with either sham or active coils. The results show both short and long-term benefits of active rTMS treatment but also show similar benefits for sham coil treatment of mild/moderate AD. We discuss this finding in the context of the existing literature on rTMS therapy for AD, as well as evidence of the sham coil's potential to induce a low-level current in the brain. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT02908815.
27
Cerebral Blood Flow in Dementia
Vladimir Hachinski, L. D. Iliff, E. Zilhka et al. · Archives of Neurology · 1975 · 3.2K citations
Medicine, Neurology, Neuroscience +14
The number needed to treat: a clinically useful measure of treatment effect
Richard J. Cook, D L Sackett · BMJ · 1995 · 1.9K citations
Mohamed A. Ahmed, Esam S. Darwish, Eman M. Khedr et al. · Journal of Neurology · 2011 · 304 citations